These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1681 related articles for article (PubMed ID: 1701519)

  • 41. Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis.
    Paradiso A; Ranieri G; Silvestris N; Naccarato G; Bevilacqua G; Mangia A; Leone B; Vallejo C; Simone G; Schittulli F; De Lena M
    Clin Exp Med; 2001 Sep; 1(3):127-32. PubMed ID: 11833848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
    Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor angiogenesis as a prognostic factor in cervical carcinoma.
    Wiggins DL; Granai CO; Steinhoff MM; Calabresi P
    Gynecol Oncol; 1995 Mar; 56(3):353-6. PubMed ID: 7535719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
    Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
    J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inverse relationship between microvessel counts and tumor volume in breast cancer.
    Wapnir IL; Barnard N; Wartenberg D; Greco RS
    Breast J; 2001; 7(3):184-8. PubMed ID: 11469933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.
    Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sakurai M; Sowa M
    Br J Cancer; 1995 Jun; 71(6):1297-301. PubMed ID: 7779727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
    Gong Y; Sun X; Huo L; Wiley EL; Rao MS
    Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
    Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
    J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical analysis of angiogenesis in invasive ductal breast carcinoma with correlations to clinicopathological factor].
    Ivković-Kapicl T; Knelević-Usaj S; Panjković M; Mastilović K
    Vojnosanit Pregl; 2006 Jul; 63(7):635-42. PubMed ID: 16875423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of neovascularisation to metastasis of non-small-cell lung cancer.
    Macchiarini P; Fontanini G; Hardin MJ; Squartini F; Angeletti CA
    Lancet; 1992 Jul; 340(8812):145-6. PubMed ID: 1378165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor angiogenesis in gallbladder carcinoma.
    Sugawara Y; Makuuchi M; Harihara Y; Noie T; Inoue K; Kubota K; Takayama T
    Hepatogastroenterology; 1999; 46(27):1682-6. PubMed ID: 10430321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.
    Weidner N
    Breast Cancer Res Treat; 1995; 36(2):169-80. PubMed ID: 8534865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density.
    Hansen S; Grabau DA; Rose C; Bak M; Sørensen FB
    Lab Invest; 1998 Dec; 78(12):1563-73. PubMed ID: 9881956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.
    Foote RL; Weidner N; Harris J; Hammond E; Lewis JE; Vuong T; Ang KK; Fu KK
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):745-53. PubMed ID: 15708253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of thymidine phosphorylase in human gastric carcinoma.
    Takebayashi Y; Miyadera K; Akiyama S; Hokita S; Yamada K; Akiba S; Yamada Y; Sumizawa T; Aikou T
    Jpn J Cancer Res; 1996 Mar; 87(3):288-95. PubMed ID: 8613432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.
    Raica M; Cimpean AM; Ceausu R; Ribatti D
    Anticancer Res; 2011 May; 31(5):1757-64. PubMed ID: 21617236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer.
    Hildenbrand R; Dilger I; Hörlin A; Stutte HJ
    Pathol Res Pract; 1995 Jun; 191(5):403-9. PubMed ID: 7479358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.